BGMEA UNIVERSITY OF FASHION &

TECHNOLOGY

ID: 182-033-401
182-047-401
182-021-401

Subject
Financial Management

Beximco Pharmaceuticals Ltd

Beximco Pharmaceuticals Ltd. is a leading manufacturer and exporter
of medicines in Bangladesh. Incorporated in 1976, the company
started its operation by importing products from Bayer, Germany
and Upjohn, USA and selling them in the local market. In 1980
Beximco began manufacturing of these products under licensing
arrangement and launched its own formulation brands in 1983. From
that humble beginning, Beximco Pharma has grown from strength to
strength, and today it has become an emerging global generic drug
company from the region.

Financial Statement Analysis

Year 2016-2017 2017-2018 2018-2019

Finance Cost 557,003,162 540,283,443 1,029,762,542
TOTAL ASSETS 34,084,132,870 43,738,886,412 49,214,092,360
Cash Equivalents 275,028,025 369,108,554 428,358,955
Profit 12,568,719 14,631,128 22,750,454
EQUITY AND LIABILITIES 34,084,132,870 43,738,886,412 49,214,092,360
Total Sales 15,509 M 17,717 20,435
M M

SQUARE FORMULATIONS LIMITED

SQUARE Pharma, the largest pharmaceuticals company in the
Country, is a trusted name in the pharmaceuticals sector of
Bangladesh. Like most indigenous concern it made its debut in a
humble way in 1958 as a Partnership Firm under the leadership of
Late Samson H Chowdhury. The following year, 12 working people,
occupied floor space of 3,000 sq. ft., first production EASTON’S syrup
and made a turnover of Tk. 55,000.

Financial Statement Analysis

Year 2016-2017 2017-2018 2018-2019

Finance Cost 438,395,758 500,758,632 657,759,285
TOTAL ASSETS 20,345,963,354 23,155,528,354 30,366,988,863
Cash Equivalents 7,653,958,836 10,183,997,963 15,708,004,696
Profit 8,258,965 9,797,321 10,378,582
EQUITY AND LIABILITIES 45,763,246,051 50,654,856,982 52,474,995,483
Total Sales 10,066 M 15,353 18,655
M M

ACME Laboratories Ltd

The Company has a very positive financial ratio as evident from
financial summary given on this Annual Report. Such positive
financial ratios indicate Company’s sound financial strength and good
prospects.
 Financial Statement Analysis

Year 2016-2017 2017-2018 2018-2019

Total Shares 211,601,700 354,453,743 444,656,350
Revenue 13,576.32 15,453.53 20,653.44
Asset Value 80.13 85.12 90.06
Profit 4,039.289 4,453.345 5,432.345
EQUITY AND LIABILITIES 20,632.19 23,456.432 29,425.45
Total Sales 15,000 crore 16,000 crore 20,000 crore